drugset / Trial / NCT03249259

The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes

NCT03249259

Phase 3 Completed 36 enrolled Seoul National University Bundang Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

In this study, the investigators are going to investigate the efficacy of choline alfoscerate on improvement of cognitive function assessed by MMSE compared to plaebo.

Timeline

Start
2016-03-10
Primary completion
2019-06-30
Completion
2019-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Choline Alfoscerate Unknown 400 mg